Companies Dominating the Ferritin Testing Landscape
- Sekisui Diagnostics, LLC.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- bioMérieux SA
- Thermo Fisher Scientific Inc.
- ORGENTEC Diagnostika GmbH
- Eurolyser Diagnostica GmbH
- Cortez Diagnostics Inc.
- HORIBA Ltd.
- Monobind Inc.
- Aviva Systems Biology Corporation
- Abnova Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of ferritin testing is evaluated at USD 762.81 million.
The ferritin testing market size was valued at USD 658.86 million in 2024 and is expected to reach USD 2.14 billion by 2037, registering around 9.5% CAGR during the forecast period i.e., between 2025-2037. The rise in geriatric population all across the globe, and less awareness of iron deficiency across the globe will boost the market growth.
North America industry is poised to hold largest revenue share of 35% by 2037, impelled by rising healthcare expenditure in the region.
The major players in the market are Sekisui Diagnostics, LLC., bioMérieux SA, Thermo Fisher Scientific Inc., ORGENTEC Diagnostika GmbH, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., HORIBA Ltd., Monobind Inc., Aviva Systems Biology Corporation, Abnova Corporation
